While CRISPR "molecular scissors" have captured the global imagination by cutting and fixing DNA, a parallel revolution is quietly unfolding through "add-a-gene" strategies.

This episode explores the world of next-generation gene therapies—treatments that don’t just edit existing code, but instead use custom-engineered viruses to deliver entirely new, working copies of missing genes to cells.

With approximately 32 gene therapies already approved globally as of 2024, we are witnessing an unstoppable rise in treatments for once-untreatable conditions, from inherited blindness to spinal muscular atrophy and hemophilia.

We dive into the "firsts" of 2024, highlighting how giving a cell the single piece of information it lacks can transform a lifelong disability into a story of progress.

We also address the complex reality behind these breakthroughs: the staggering price tags, the intense regulatory wrangling, and the sophisticated engineering required to turn a virus into a life-saving delivery vehicle.

Looking toward 2050, we glimpse a future of routine pediatric screenings and advanced non-viral vectors that could make genetic "additions" as common as antibiotics.

Join us as we spotlight the new paradigm for genetic disease, where adding what’s missing is the key to rewriting a patient's destiny.